Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
about
Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosisOptical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderOptical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative DiseasesFatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathwaysRetinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypesIn vivo evaluation of retinal neurodegeneration in patients with multiple sclerosisOptical coherence tomography (OCT) in optic neuritis and multiple sclerosis.Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.[Diagnosis and monitoring of multiple sclerosis: the value of optical coherence tomography].Optical coherence tomography as a biomarker in multiple sclerosis.Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.The visual pathway as a model to understand brain damage in multiple sclerosis.Vision and vision-related outcome measures in multiple sclerosis.Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study.Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry.Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitationsEffect of optic neuritis on progressive axonal damage in multiple sclerosis patients.Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology.Computational classifiers for predicting the short-term course of Multiple sclerosis.Retinal imaging as a source of biomarkers for diagnosis, characterization and prognosis of chronic illness or long-term conditionsAxonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesionsLongitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients.Color vision is strongly associated with retinal thinning in multiple sclerosis.Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomographyMultiple sclerosis and optic nerve: an analysis of retinal nerve fiber layer thickness and color Doppler imaging parameters.Associations between retinal nerve fiber layer abnormalities and optic nerve examination.Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-beta.Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.Cup to disc ratio by optical coherence tomography is abnormal in multiple sclerosis.Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosisComparison of retinal nerve fiber layer measured by time domain and spectral domain optical coherence tomography in optic neuritis.Microcystic macular oedema in multiple sclerosis is associated with disease severityAdding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis.Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.
P2860
Q24650437-C310CEEA-AC89-49DD-9C0A-FF9A511AEC7CQ28076588-100D1A4D-7AAE-4C98-AA42-0F8A06AB431DQ28080265-01EFC70F-B91D-43F2-8882-0E87EFD750A7Q28299922-7D2C7D1B-58B0-433E-8BA0-D3AC283E5426Q28729713-7FE27744-9080-4E26-BED7-DFDD903E7F49Q28732415-3045DED2-B546-421D-86AF-D0BB19D80FD9Q30497714-8981A173-66F1-474E-80EA-5DB0518FDBBAQ30499517-6454E7F5-772F-416D-A750-78802C750311Q30591135-15E730F0-9422-4912-8ED1-A56A2B0DFF6BQ30597564-184E1FA0-DF11-4A2D-A9AB-45AB5A5A70EDQ30649660-C01019EC-7EB8-4E7E-BF87-23592D93264CQ30676331-7B22815F-E1C0-41E9-BFF4-D7327D5CFFFDQ30836017-A6569F5F-9CF6-442D-85D2-D57775332EDAQ30872452-C301AEF4-756E-4CD6-8972-999EA530FFFDQ33547267-77C9C787-9546-43B9-820D-34BE89A7A120Q33576003-0A17CDF2-6B13-4635-89C4-B8EEDC201E24Q33648360-B663802E-4D00-433F-A4B6-53E8829560A2Q33747645-F64FFC2A-6392-45C5-AE45-8B4DD25FD252Q33814175-00E1CCEC-068E-4906-91D7-107531BBFD38Q33882723-D4560E93-5073-4525-93CB-8EEECB0E7B29Q33882744-022A3C11-4E4E-4165-B7DE-62AA56E29CDEQ33925740-CB479A78-B43D-4921-A9BB-41A193E519CEQ33956257-67A94583-E39D-48F6-B3EE-7CFDA275B7FAQ33961780-5993C562-EE77-4BB2-B6FE-4D84DB2FD57CQ33983613-4557658C-65B5-432A-9BBA-A3BE86CCC1BAQ34076168-D02D790C-800A-433E-A5E0-CFBDF8BBF529Q34104774-770F5077-6640-4C64-BF0B-EF411B8AC92EQ34145469-9BF5406D-5653-4BCC-9F16-8E43E0A4803CQ34161093-1505EF0B-A09F-403D-B977-FA04E4A136E7Q34325602-1087894E-7903-4957-BC24-6F0A3A53EDA8Q34455112-90A583E2-C9AD-439A-A4D5-C2EE930ACDA3Q34525419-2FAAC4B2-9EB8-4120-8940-653CE7474907Q34771809-9519E439-6D60-4F53-86F6-B568F566FE32Q34785270-A3A1C4A1-1BFE-4DF1-BA42-C1F9B004E3D4Q35015198-0940017E-EDA8-4959-94F8-FAD6D7F1EF98Q35082356-166F56E7-C53A-4948-A262-C5375661DECDQ35203029-03646361-046D-416E-8D22-61CEBD6FBE86Q35986688-4792452A-FEDF-4D3F-8F2D-E7843C642B5DQ36015674-CA07AC4B-419F-47F7-8103-4E267CF45F19Q36063052-70F731B3-37E7-4DDF-8245-9A43018160A3
P2860
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
@ast
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
@en
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
@nl
type
label
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
@ast
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
@en
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
@nl
prefLabel
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
@ast
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
@en
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
@nl
P2093
P1433
P1476
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
@en
P2093
Alfredo García-Layana
Angel Salinas-Alaman
Bartolome Bejarano
Manuel Murie-Fernandez
P304
P356
10.1212/01.WNL.0000260612.51849.ED
P407
P577
2007-05-01T00:00:00Z